Drugs / CHS-1000
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06389526 | Feb 2025 → May 2028 expected | — | Coherus Oncology, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHS-1000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06389526 ↗ |